Follicle Stimulating Hormone-Regulated Expression of Serum/Glucocorticoid-Inducible Kinase in Rat Ovarian Granulosa Cells: A Functional Role for the Sp1 Family in Promoter Activity
Tamara N. Alliston,
Anita C. Maiyar,
Patricia Buse,
Gary L. Firestone and
JoAnne S. Richards
Department of Cell Biology (T.N.A., J.S.R.) Baylor College of
Medicine Houston, Texas 77030
Department of Molecular and
Cell Biology (A.C.M., P.B., G.L.F.) University of California
Berkeley, California 94720
 |
ABSTRACT
|
---|
Recently, a family of novel, serine/threonine
protein kinases has been identified. One of these transcriptionally
inducible, immediate-early genes encodes serum/glucocorticoid
inducible-protein kinase, sgk. By in situ
hybridization, we show that sgk expression in the rat ovary
is selectively localized to granulosa cells. In culture, FSH or
forskolin, activators of the protein kinase A (PKA) pathway, rapidly (2
h) and transiently increased sgk mRNA levels in
undifferentiated granulosa cells. Sgk mRNA exhibited a
biphasic expression pattern, with maximal levels observed at 48 h
of FSH/forskolin as granulosa cells differentiate to the preovulatory
phenotype. Deletion analyses using sgk promoter-reporter
constructs (-4.0 kb to -35 bp) identified a region between -63 and
-43 bp that mediated FSH and forskolin-responsive transcription in
undifferentiated and differentiated granulosa cells. This G/C-rich
region 1) conferred both basal and inducible transcription to the
minimal -35 sgk promoter chloramphenicol acetyltransferase
reporter construct, 2) specifically bound Sp1 and Sp3 present in
granulosa cell extracts, and 3) bound recombinant Sp1. Mutation of 2 bp
in this region not only prevented Sp1 and Sp3 binding, but also
abolished the PKA-mediated transactivation observed when using the wild
type construct. Sp1 and Sp3 DNA-binding activity and protein levels did
not change significantly during sgk induction.
Collectively, these data indicate that Sp1/Sp3 transactivation of the
sgk promoter likely involves regulated,
phosphorylation-dependent interaction with other factors. Thus the
novel, biphasic induction of sgk that correlates with
granulosa cell progression from proliferation to differentiation
appears to involve sequential, coordinated actions of FSH, PKA, and
transcription factors, including Sp1 and Sp3.
 |
INTRODUCTION
|
---|
Cells respond to their environment by activating cellular
signaling pathways, many of which converge upon the nucleus to
coordinate gene expression. A novel family of serine/threonine kinases,
distinguished by their immediate-early transcriptional induciblity, has
added a new dimension to our understanding of the regulation of kinase
activity. Serum/glucocorticoid inducible protein kinase,
sgk, a member of this family, was initially identified as a
gene whose transcription was rapidly induced by glucocorticoids in rat
mammary tumor cells (1). Sgk transcription is also inducible
by serum (2) and by cortical injury to the rat brain (3). Therefore,
unlike other kinases that are constitutively present in cells and are
activated by post-translational mechanisms such as phosphorylation or
ligand binding, sgk and its family members, serum inducible
kinase, snk (4), fibroblast growth factor inducible kinase,
fnk (5), and proliferation related kinase, prk
(6), are rapidly transactivated in response to specific hormonal and
environmental stimuli. The induction of these kinases requires new
transcription, is independent of new protein synthesis, and is often
associated with increased cellular proliferation (1, 2, 4, 5, 6). In fact,
snk was identified as a gene up-regulated in dividing cells
(4), whereas sgk is induced by serum as quiescent
fibroblasts begin to proliferate (2). Interestingly, sgk is
also transactivated during differentiation, as shown by the induction
of sgk transcription in mammary tumor cells as they
differentiate in response to glucocorticoids (1). Furthermore, the
highest levels of sgk transcripts have been detected in
differentiated adult tissues, such as the lung, thymus, and ovary (1).
Collectively, these previously described results set sgk
apart as a kinase that can be rapidly induced in cells during both
proliferation and differentiation.
Sgk expression was first detected in RNA prepared from rat
ovary; therefore, neither the cell types in which it was expressed nor
the hormones regulating its expression were known. Our preliminary data
showed that sgk was expressed in the FSH-responsive ovarian
granulosa cells (7). Therefore, we hypothesized that sgk was
an attractive candidate for immediate-early transcriptional regulation
by FSH, the physiological agonist of granulosa cell proliferation (8)
and differentiation (9).
FSH coordinates the development of ovarian follicles from the small
antral stage to the fully differentiated preovulatory stage (9). During
this progression, FSH increases granulosa cell
[3H]thymidine uptake (10) while stimulating the
sequential expression of several differentiation stage-specific genes
(9). For example, in undifferentiated granulosa cells FSH transiently
induces cyclin D2 mRNA, itself encoding a critical regulator of
granulosa cell proliferation (11). However, FSH induction of granulosa
cell differentiation-specific genes, such as aromatase cytochrome P450
(12), cholesterol side-chain cleavage cytochrome P450 (13), and LH
receptor (14), occurs only after 2448 h of FSH exposure. Therefore,
FSH can elicit a range of cellular responses that occur in a defined
temporal sequence, involving both immediate-early and delayed effects,
one of which we hypothesize is the induction of sgk.
FSH exerts its effects on granulosa cells by binding to a
ligand-specific G protein-coupled membrane receptor that activates
adenylyl cyclase (9, 15). This leads to cAMP production and activation
of cAMP-dependent protein kinases [protein kinase A (PKA)] (16).
Activated PKA is known to phosphorylate specific transcription factors,
thereby modulating their activity and regulating gene expression (16, 17). Indeed, PKA phosphorylates cAMP-regulatory element-binding protein
(CREB) (18), enabling it to interact with other factors present in
granulosa cells to induce aromatase transcription (19). Although some
of the molecular mechanisms by which FSH regulates gene expression
during differentiation have been defined, less is known about genes
rapidly induced by FSH and the mechanisms employed to mediate this
induction, particularly in undifferentiated granulosa cells. For these
reasons, and because sgk is an immediate-early gene in other
tissues (1, 2), we aimed to identify the pattern of sgk
expression throughout FSH-stimulated granulosa cell development and to
determine the molecular mechanisms regulating its expression.
For these studies we used a well characterized, primary granulosa cell
culture system in which FSH is known to stimulate specific changes in
granulosa cells that mimic the proliferation and differentiation
occurring in vivo as small antral follicles become
preovulatory follicles (9). This system allowed us to directly examine
the effects of FSH on the endogenous expression of the sgk
gene, as well as on the expression of transgenes derived from the
sgk promoter in granulosa cells at both the undifferentiated
small antral and differentiated preovulatory stages. Our results show
that sgk expression in undifferentiated rat granulosa cells
is induced rapidly by activators of the PKA pathway, declines, and then
reaches maximal levels as cells differentiate in vitro in
response to FSH. We document that a G/C-rich region in the
sgk promoter is essential for Sp1 and Sp3 binding.
Furthermore, we show for the first time that the binding of Sp1 and/or
Sp3 is critical for basal and FSH-inducible transcription of the
sgk gene in both undifferentiated and differentiated
granulosa cells.
 |
RESULTS
|
---|
Localization of sgk mRNA Expression in the Ovary
Although sgk mRNA was detected in the adult rat ovary
(1), the localization of sgk expression within this tissue
was unknown. Therefore, ovaries from adult cycling rats were prepared
for in situ hybridization to identify the ovarian cell types
expressing sgk. Using a radiolabeled antisense
sgk riboprobe, sgk mRNA expression was detected
at highest levels in preovulatory follicles rather than in interstitial
tissue (Fig. 1
). In these follicles,
sgk mRNA was localized preferentially to the mural granulosa
cells. Low amounts of sgk mRNA were detected in the
interstitial tissue and in outer thecal cells, but no sgk
mRNA was detected in the oocyte or in the cumulus granulosa cells
surrounding the oocyte. Use of a radiolabeled sense sgk
riboprobe as a negative control confirmed the specificity of the
sgk signal. The expression of sgk in the
FSH-responsive preovulatory granulosa cells led us to investigate the
ability of FSH to directly regulate sgk transcription in
cultured granulosa cells.

View larger version (122K):
[in this window]
[in a new window]
|
Figure 1. Localization of sgk mRNA Expression
The top two panels are bright-field photographs of
hematoxylin- and eosin-stained ovarian tissue sections acquired from
adult cycling rats. Dark-field photographs of the same region reveal
staining resulting from in situ hybridization using
antisense sgk riboprobe (lower left) or
sense sgk riboprobe (lower right).
Dark-field photos were exposed using identical conditions. The majority
of the specific staining localizes to the granulosa cells in the
preovulatory follicle.
|
|
Regulation of sgk mRNA and Protein Expression in
Cultured Small Antral Granulosa Cells
To investigate the ability of FSH to regulate sgk
expression, we analyzed FSH-responsive changes in sgk mRNA
and protein levels. Total RNA was isolated from primary granulosa cell
cultures after 0, 1, 2, 4, 6, 12, or 48 h of treatment with FSH
and testosterone (T) and was examined by Northern analysis. T was used
to maintain optimal FSH responsiveness of granulosa cell cultures (20).
In granulosa cells cultured overnight in the absence of hormone,
sgk mRNA levels were very low (Fig. 2A
). Addition of FSH/T stimulated a rapid
increase in sgk mRNA that reached a peak at 2 h and
then declined by 6 h. Although all time points examined are not
shown in this representative Northern blot, sgk mRNA levels
gradually increased between 12 and 48 h of FSH/T. The maximal
expression of sgk at 48 h of FSH/T coincides with
granulosa cell differentiation to the preovulatory phenotype in
vitro; as is demonstrated by the concurrent expression of another
preovulatory granulosa cell-specific gene, aromatase (21). Forskolin, a
PKA agonist that directly activates adenylyl cyclase, yields an
identical, although more robust, pattern of sgk mRNA
induction (data not shown).

View larger version (40K):
[in this window]
[in a new window]
|
Figure 2. Expression of sgk mRNA and Protein
in Response to FSH/T in Cultured Granulosa Cells
Granulosa cells plated on serum-coated dishes were cultured overnight
in hormone-free medium. At that time (t = 0), FSH/T or forskolin
was added and RNA (A), protein (B), or media (C) was harvested at the
indicated times. A, Twenty micrograms of RNA were examined by Northern
blot analysis using an sgk cDNA as the labeled probe
(upper panel). Acridine orange staining was used to
visualize 28S and 18S RNA (lower panel). B, Soluble cell protein (100
µg) isolated from cultured granulosa cells was examined by Western
blot analysis with an Sgk antibody. Recombinant Sgk protein in
bacterial extracts (Sgk extract, 55 kDa) was used as a positive
control. C, cAMP concentrations in media of FSH/T-stimulated granulosa
cells were analyzed by RIA.
|
|
To determine whether the induction of sgk mRNA by FSH
or forskolin resulted in a corresponding increase in cellular Sgk
protein content, soluble cell extracts were examined by Western blot
analysis using a polyclonal Sgk antibody. Recombinant Sgk protein
(Mr = 55,000) was used as a positive control (Fig. 2B
). Low
amounts of immunoreactive Sgk protein were present in granulosa
cells cultured overnight in the absence of serum and hormones. Addition
of forskolin caused an increase in two immunoreactive bands by 6
h. The large protein corresponds to full-length Sgk protein, whereas
the other may represent a partially degraded form of the kinase or a
closely related Sgk-like protein. The highest amounts of Sgk protein
were observed at 48 h after the addition of forskolin. FSH/T
caused a pattern of Sgk induction similar to that seen with forskolin,
but with lower levels at earlier time points. However, after 48 h
of FSH/T, Sgk protein levels were high and equivalent to those detected
with 48 h of forskolin. Thus, the time course and magnitude of
Sgk protein expression paralleled the biphasic induction of
sgk mRNA by FSH or forskolin.
The biphasic induction of sgk mRNA and protein appears to
require the sustained activation of the PKA pathway. First, FSH alone
can induce sgk, whereas T alone does not (data not shown).
Second, FSH, a known activator of the PKA pathway, causes a rapid and
exponential increase in granulosa cell cAMP levels (69 pmol/ml) at
2 h (Fig. 2C
). Although cAMP levels decline by 48 h of FSH/T,
the cAMP concentration (15 pmol/ml) remained approximately 30-fold
higher than that in untreated cells (0.5 pmol/ml). Third, the
forskolin-induced pattern of sgk mRNA expression is
identical to that seen using FSH/T (data not shown). Therefore,
sgk transcription is inducible by activation of the PKA
pathway with an immediate early peak at 2 h and a secondary
maximal peak as granulosa cells differentiate.
Translation-Independent Induction of sgk mRNA
To determine whether the FSH induction of sgk
mRNA in granulosa cells was a transcriptionally mediated response, as
has been previously shown in other cell types (2), granulosa cells were
cultured in the presence of cycloheximide (CHX), an inhibitor of
protein synthesis, or
-amanitin, a transcriptional inhibitor. To
assay the immediate-early response, undifferentiated granulosa cells
were treated with CHX and/or FSH/T for 2 h. The FSH/T induction of
sgk mRNA was not blocked by the presence of CHX, indicating
that de novo protein synthesis is not required for
sgk transcription at 2 h (Fig. 3
). When CHX was added alone to the
cultures, sgk mRNA increased over basal levels,
demonstrating that steady-state levels of sgk mRNA are
susceptible to a CHX-sensitive step (22). Importantly, in the same time
interval,
-amanitin blocked FSH/T induction of sgk mRNA.
Together, these data show that the FSH-responsive increase in
sgk mRNA levels in undifferentiated granulosa cells is
immediate-early and transcriptionally dependent.
To assess the transcriptional inducibility of sgk mRNA
in differentiated granulosa cells, CHX or
-amanitin was added to
granulosa cells that had been cultured for 41 h with FSH/T (Fig. 3
). RNA was harvested after 41 or 48 h of treatment and examined
by Northern analysis. Although a 7-h exposure to
-amanitin caused a
loss of sgk mRNA, CHX had no effect. These data suggest that
transcriptional induction resulting in the secondary peak of
sgk mRNA in differentiating granulosa cells is independent
of new protein synthesis.
Seventy Eight Base Pairs of the sgk Promoter Contain
cis-Acting DNA Elements Critical for Inducible
Transcription
To identify regions of the sgk promoter that mediate
the FSH induction of sgk transcription in granulosa cells,
vectors containing -4000, -1500, -360, -78, or -35 bp of the
sgk promoter ligated to the chloramphenicol
acetyltranscriptase (CAT) reporter gene were transfected into granulosa
cells that had been cultured overnight in the absence of serum and
hormone (Fig. 4
). After a 4-h
transfection, the cells were stimulated with forskolin for 6 h or
were left untreated. Forskolin increased CAT activity of the
transfected -4000 sgk-CAT, -1500 sgk-CAT, -360 sgk-CAT, and -78
sgk-CAT vectors by 4-fold, 5-fold, 3-fold, and 7-fold, respectively,
compared with levels in untreated cells. The shortest deletion
construct containing only minimal promoter elements, -35 sgk-CAT, was
not forskolin inducible. Similar results were observed when FSH/T,
rather than forskolin, was added to the transfected cells (data not
shown). The -78 sgk-CAT construct also exhibited forskolin-responsive
transcription when examined in differentiated granulosa cells (cells
treated with 37 h FSH/T followed by transfection and 6 h
forskolin stimulation) (Fig. 8B
). Thus, the region between -78 and
-35 bp of the sgk promoter was sufficient and necessary to
confer transcriptional inducibility to the reporter gene at both the
immediate-early (2 h) and the late (48 h) phases of sgk
transcription.

View larger version (25K):
[in this window]
[in a new window]
|
Figure 4. Forskolin Inducibility of the sgk
Promoter
Granulosa cells were cultured overnight in serum and hormone-free media
and then transfected with constructs containing 4000 bp, 1500 bp, 360
bp, 78 bp, or 35 bp of the sgk promoter linked to a CAT
reporter gene. Cells were incubated 4 h for transfection of
calcium phosphate DNA precipitate and then 6 h in the presence or
absence of forskolin. pCAT control and pCAT basic plasmids were used as
positive and negative controls, respectively, for all CAT assays (data
not shown). Cell extracts were assayed for CAT activity for 2 h.
Results are shown as percent conversion of
[14C]chloramphenicol.
|
|

View larger version (34K):
[in this window]
[in a new window]
|
Figure 8. Role of the G/C Box in the Hormone Induction of the
sgk Promoter
As detailed in the previous figure, undifferentiated granulosa cells
(A) were transfected with constructs containing portions of the
sgk promoter linked to the CAT reporter gene. The -63
mut sgk-CAT construct contains a mutation in the G/C box (CC to AA) as
indicated. After transfection, cells were incubated for 6 h in the
presence or absence of FSH/T. B, Other granulosa cells were cultured
with FSH/T for 37 h to allow differentiation before the 4-h
transfection with the same constructs. Then cells were washed and
incubated for 6 h in the presence or absence (0) of forskolin.
This regimen mimicked the 48-h culture period of FSH/T alone when
sgk mRNA levels were maximal. CAT activity of all cell
extracts was assayed for 7 h. Results are shown as percent
conversion of [14C]chloramphenicol.
|
|
Specific Binding of Protein Complexes to -78/-35 of the
sgk Promoter
The transcriptionally active region from -78 to -35 bp of the
sgk promoter contains several transcription factor
consensus-binding sites. An Sp1 site and an AP-2 site are upstream of
another G/C-rich region, referred to here as the G/C box. The G/C box
itself contains three overlapping Sp1 sites and an additional AP-2 site
(Fig. 5A
). Because these consensus
sequences potentially bind AP-2 and multiple members of the Sp1 family,
several proteins are candidate enhancers of sgk
transcription. To determine whether the -78/-35 region of the
sgk promoter did, indeed, bind specific proteins,
oligonucleotides corresponding to various fragments of this region were
constructed for use in electrophoretic mobility shift assays (EMSAs).
When the -78/-35 bp oligonucleotide spanning the entire functional
region was used as a radiolabeled probe, four major protein/DNA
complexes were formed in the presence of granulosa whole cell extracts
(Fig. 5B
). These complexes (I, II, III, IV) were specifically competed
by 100-fold excess of unlabeled -78/-35 self-competitor DNA. When
unlabeled oligonucleotides spanning a 3'-region (-55/-35 bp), a
5'-region (-78/-50 bp), or the central region (-63/-43 bp) of the
-78/-35 oligonucleotide were used as competitors, only the central
(-63/-43 bp) oligonucleotide effectively competed for all complexes.
Although oligonucleotides corresponding to the 3'-region (-55/-35 bp)
and 5'-region (-78/-50 bp) of the sgk promoter could
partially compete for binding of complex III and completely compete for
binding of complex IV, we focused on the central region (-63/-43 bp)
as it was the only oligonucleotide that formed all four specific
protein/DNA complexes with granulosa whole cell extracts when it was
used as a labeled probe (Fig. 5C
).

View larger version (28K):
[in this window]
[in a new window]
|
Figure 5. Specific Binding of Granulosa Cell Proteins to
-78/-35 bp of the sgk Promoter
Whole cell extracts (WCE) used in all EMSAs were prepared from
granulosa cells cultured overnight in hormone-free media before 1
h exposure to FSH unless otherwise indicated. A, A schematic of
oligonucleotides spanning the sgk promoter identifies
the consensus transcription factor-binding sites within the
transcriptionally active region and the oligonucleotides used in EMSA
analysis that span each region. B, Complexes (I-IV) formed with WCE
incubated with the -78/-35 bp sgk oligonucleotide
probe. Oligonucleotides corresponding to -78/-35, -78/-50,
-55/-35, and -63/-43 bp of the sgk promoter were
used as competitor DNA. C, Wild type or mutant -63/-43 bp
sgk oligonucleotides were used as probes or unlabeled
competitor DNA with WCE to assess the role of the G/C box.
|
|
To assess the role of the G/C box in protein/DNA complex formation,
another -63/-43 oligonucleotide was synthesized with the CC at
position 48/-47 bp mutated to AA. When EMSAs were performed using the
wild type -63/-43 oligonucleotide as the labeled probe with granulosa
cell extracts, complexes I-IV were formed and were competed by excess
self-competitor DNA (Fig. 5C
). The mutated -63/-43 oligonucleotide
failed to compete for the binding of protein in the major complexes I
and II. However, the mutant oligonucleotide did compete partially for
complex III or completely for complex IV. When this mutated -63/-43
oligonucleotide was used as a labeled probe, complexes I and II were
not formed. Complexes III and IV were detected, but at levels lower
than those detected using the wild type probe. These results showed
that the formation of two major, specific protein/DNA complexes (I and
II) critically depend upon an intact G/C box with its overlapping Sp1
and AP-2 sites for binding.
Identification of Protein/DNA Complexes
To determine whether either AP-2 protein or Sp1 protein family
members bound the -63/-43 region of the sgk promoter, AP-2
and Sp1 consensus sequence oligonucleotides and antibodies were used in
additional EMSAs. While the labeled -63/-43 oligonucleotide formed
complexes I-IV that were competed by 100-fold excess unlabeled
self-competitor DNA, these complexes were not competed by the same
amount of an AP-2 consensus oligonucleotide. Nor did the addition of
anti-AP-2 polyclonal antibody supershift or diminish the formation of
these complexes. Based on these results, we conclude that AP-2 is not a
major factor in granulosa cell extracts binding to this region of the
sgk promoter (data not shown).
In contrast, use of the Sp1 consensus binding sites, antibodies, and
recombinant protein in EMSAs suggest that the consensus Sp1-binding
sites in the G/C box bind Sp1 present in granulosa cell extracts.
Again, complexes I-IV were formed with labeled -63/-43 bp probe and
were competed with unlabeled wild type -63/-43 oligonucleotide (Fig. 6A
, lanes 2 and 3). Sp1 competitor DNA
effectively competed for the binding of complexes I and II (lane 5)
compared with the mutant -63/-43 oligonucleotide (lane 4). Incubation
of the -63/-43 probe with recombinant Sp1 protein resulted in the
formation of a protein/DNA complex with the same mobility as complex I
(Fig. 6A
, lane 6). This Sp1 complex was competed by excess self (lane
7) but not mutant oligonucleotides (lane 8) and was competed by Sp1
competitor DNA (lane 9). This specific Sp1 complex was completely
supershifted upon incubation with a polyclonal Sp1 antibody (lane
10).

View larger version (57K):
[in this window]
[in a new window]
|
Figure 6. Identification of the Protein/DNA Complexes
A, Unlabeled -63/-43 wt (self) and mutant sgk
oligonucleotides and Sp1 consensus site DNA (six copies) were used to
compete the formation of the protein/DNA complexes formed between a
-63/-43 sgk oligonucleotide probe and granulosa cell
WCE or recombinant human Sp1 protein. Incubation of recombinant Sp1
protein with Sp1 antibody caused the formation of a supershifted
complex (*) that was not detected upon incubation of antibody with the
probe alone (lane 11). B, When the same probe was incubated with
granulosa cell WCE in the presence of Sp1 and/or Sp3 antibody, the
formation of complexes I and II, respectively, were decreased in
association with the formation of supershifted bands (*). These
supershifted bands were not detected upon incubation of Sp3 antibody
with probe alone (lane 1).
|
|
With the specificity of the Sp1 antibody confirmed, the antibody was
then used in EMSAs with granulosa cell extracts to more specifically
determine the identity of complex I. When incubated with the -63/-43
sgk probe in the presence of granulosa cell extracts, the
Sp1 antibody decreased the formation of complex I and formed a
supershifted band (Fig. 5B
, lane 3) that was not detected upon
incubation of the probe with antibody alone (Fig. 5A
, lane 11). As has
been shown previously, this antibody causes a partial supershift with
cell extracts, most likely because the peptide region used to generate
the antibody can be posttranslationally modified in vivo
(23). Therefore, protein/DNA complex I formed between the G/C box of
the sgk promoter and granulosa cell whole cell extracts
contains Sp1.
Similarly, to determine the identity of complex II, which was also
competed by Sp1 consensus oligonucleotides, antibodies against another
Sp1 family member, Sp3 (24), were used for supershift analysis. The Sp3
antibody specifically decreased the formation of complex II (Fig. 5B
, lane 4) while forming a supershifted band that was not observed in the
presence of probe and antibody alone (lane 1). The Sp3 antibody does
not cross-react with Sp1 as incubation of the Sp3 antibody with
recombinant Sp1 protein did not result in a supershift or depletion of
this complex (data not shown). However, incubation of Sp1 antibody and
Sp3 antibody together with granulosa cell extracts resulted in the
decrease of both complexes I and II and formation of supershifted bands
(lane 5). Therefore, in addition to binding Sp1, the consensus
Sp1-binding sites in the sgk G/C box also bind Sp3, detected
in complex II.
Sp1 Sites Mediate FSH-Stimulated Transcription
To determine whether Sp1 sites were able to mediate an
FSH-responsive induction independently of the sgk promoter
context, we transfected a construct containing six Sp1 sites upstream
of a basal promoter and luciferase reporter, pGAGC6 (25), into primary
undifferentiated granulosa cells that had been cultured overnight in
serum and hormone-free conditions. As a control, the same vector
without the Sp1 sites, pGAM (25), was transfected into identical
granulosa cell cultures. The pGAGC6 transgene exhibited much higher
levels of basal transcription (30-fold) than the pGAM construct alone
(Fig. 7
). In addition, the pGAGC6
construct showed a modest, but significant induction (2-fold) in
response to a 6-h treatment with FSH/T. The results indicate
Sp1-binding sites can confer basal and hormone-responsive transcription
in granulosa cells.

View larger version (16K):
[in this window]
[in a new window]
|
Figure 7. Role of Sp1-Binding Sites in Hormone-Responsive
Granulosa Cell Transcription
After overnight incubation in serum- and hormone-free conditions,
undifferentiated granulosa cells were transfected with pGAM or pGAGC6
vectors before 6 h of exposure to no hormone (0) or FSH/T.
Luciferase activity was assayed in protein extracts from these cultures
and is expressed as luciferase units per microgram of protein.
|
|
The G/C Box Regulates Transcription of the sgk
Promoter
To determine whether the Sp1 sites within the G/C box of the
sgk promoter could also mediate basal and hormone-induced
transactivation, both -63/-43 wild type and mutant oligonucleotides
were cloned into the minimal -35 sgk-CAT construct (Fig. 8A
). Basal and inducible activities of
these constructs were compared with the -78 sgk-CAT and -35 sgk-CAT
constructs. As shown above, the -35 sgk-CAT has minimal basal activity
and no FSH-inducible transcription when transfected into primary
undifferentiated granu-losa cell cultures. Basal transcription from
the -78 sgk-CAT and -63 sgk-CAT constructs was greater than
basal transcription seen with -35 sgk-CAT. Furthermore, FSH induced
transactivation from -78 sgk-CAT and -63 sgk-CAT by 3-fold or 2-fold,
respectively, over basal levels. When the G/C box was mutated in the
-63 sgk-CAT construct, basal levels were low and did not differ from
those seen with the minimal promoter -35 sgk-CAT construct.
Additionally, FSH induction was lost in the mutated construct. These
results were identical, but even more dramatic, when differentiated
granulosa cells were transfected after 37 h of FSH/T exposure,
before a 6-h stimulation with forskolin (Fig. 8B
). Therefore, the
presence of an intact G/C box with its overlapping Sp1-binding sites is
sufficient for basal transcription of the sgk promoter and
can mediate an FSH-responsive induction at both early and late stages
of granulosa cell differentiation.
Regulation of Sp1 and Sp3 Levels and Binding Activity
Because Sp1 and/or Sp3 binding are required for sgk
transactivation, we examined Sp1- and Sp3-binding activity and protein
levels throughout the 48-h FSH treatment period in which granulosa cell
sgk mRNA levels are biphasically induced. Granulosa cell
whole cell extracts were isolated after 0, 2, 12, 24, or 48 h
exposure to FSH/T and were then used in EMSA and Western analysis.
Incubation of these extracts with a radiolabeled -63/-43 wild type
sgk probe revealed no change in the binding of complex I
(Sp1) or complex II (Sp3) during this time (Fig. 9A
). Likewise, repeated Western analyses
of these same extracts with antibodies against Sp1 (Fig. 9B
) and Sp3
(Fig. 9C
), revealed no significant changes in either Sp1 or Sp3 protein
levels. Although Sp1 protein levels in the granulosa cells did not
change, we show that the levels of the previously described Sp1 doublet
(105 kDa and 95 kDa) (26) are high in ovarian extracts and are
comparable to levels in extracts of lung and thymus, two tissues
previously reported to express the highest levels of Sp1 (27) (Fig. 9D
). No Sp1 protein was detectable in extracts from low Sp1-expressing
tissues, muscle, and kidney (27). These data collectively suggest a
role for a coactivating factor or posttranslational modification that
regulates the transactivating potential of Sp1 and/or Sp3 in
FSH-stimulated granulosa cells.

View larger version (37K):
[in this window]
[in a new window]
|
Figure 9. Analysis of Sp1 and Sp3 Protein Levels and Binding
Activity in Response to FSH
Whole cell extracts isolated from granulosa cells cultured in FSH/T for
0, 2, 12, 24, or 48 h were isolated and examined by EMSA with the
radiolabeled -63/-43 sgk oligonucleotide probe (A) or
by Western analysis using antibodies against Sp1 (B) or Sp3 (C). D,
Similar extracts prepared from the ovary, lung, thymus, kidney, and
muscle were analyzed along with recombinant human Sp1 protein by
Western analysis with an Sp1 antibody.
|
|
 |
DISCUSSION
|
---|
This report provides the first evidence that sgk, a
member of a class of novel, transcriptionally inducible kinases, is
expressed in granulosa cells of the rat ovary, in vivo and
in vitro. Furthermore, we have shown that sgk
transcription is regulated in these cells by FSH in a biphasic pattern.
The two phases of sgk mRNA and protein induction correlate
with distinct FSH-regulated events in granulosa cell maturation,
proliferation, and differentiation. The rapid (2 h) and transient
induction of sgk by FSH is coincident with the FSH
stimulation of events regulating granulosa cell proliferation as is
detected by intense labeling of cells with [3H]thymidine
(10), BrDU staining (28), and FSH induction of cyclin D2 mRNA (11).
Cyclin D2 is a cell cycle regulator that has recently been shown to be
obligatory for granulosa cell proliferation as mice null for cyclin D2
have a dramatically reduced number of granulosa cells (11).
Sgk is also rapidly induced by serum in fibroblasts as they
enter the cell cycle from quiescence (2). Collectively, these data
suggest that the FSH-induced immediate-early expression of
sgk mRNA in granulosa cells is coincident with important
cell cycle events.
The secondary induction of sgk occurs as granulosa cells
differentiate. Maximal levels of sgk mRNA are detected after
48 h of FSH/T in vitro or in preovulatory follicles
in vivo. Not only are granulosa cells at this stage very
different from those in small antral follicles, but they are also
different from one another. For example, granulosa cells adjacent to
the antrum of the follicle are still proliferative at this time (29).
However, mural granulosa cells adjacent to the follicle basement
membrane are the first to cease cell division and to express markers of
terminal granulosa cell differentiation such as the LH receptor (30).
Interestingly, in situ hybridization at this time reveals a
gradient of sgk expression, with the highest levels seen in
the most differentiated, nonproliferative mural granulosa cells.
Therefore, the highly FSH-responsive transcriptional induction of
sgk occurs in two phases, one of which coincides with
granulosa cell proliferation and the other with granulosa cell
differentiation, suggesting multiple functions of sgk in
cell proliferation and differentiation.
Although the immediate-early transient induction of sgk
transcription has been well defined in both proliferating and
differentiating cell types in response to agonists such as serum,
glucocorticoids, or brain injury (1, 2, 3), this is the first report of a
biphasic pattern of gene expression in the ovary and of sgk
in particular. Interestingly, both phases of sgk induction
in granulosa cells by FSH or forskolin appear to depend upon the
activation of the protein kinase A pathway and are sensitive to
-amanitin but not to CHX, implicating transcriptional control in the
regulation of granulosa cell sgk levels.
Unlike the sgk gene, which exhibits both rapid and delayed
responses to FSH, genes such as aromatase are induced by FSH only after
more extended granulosa cell differentiation (21). This brings up the
interesting problem of what differs between the undifferentiated
granulosa cell and the differentiated preovulatory granulosa cell that
enables them to respond uniquely to the same signal. We have recently
shown that CREB, a PKA-activated transcription factor, is
phosphorylated in a biphasic manner in response to FSH or forskolin
(19). Phospho-CREB is detected at 2 h, decreases are detected at
6 h, and then maximal levels are reached between 24 and 48 h
of FSH treatment (19). This pattern mimics the distinctive pattern of
FSH-induced sgk transcription. Although the sgk
promoter has no detectable CRE, and we have detected no role for CREB
in sgk transactivation, these data suggest that the
phosphorylation and regulation of other nuclear transcription factors
and coactivators by PKA may also be oscillatory and obligatory for
maintaining transcription.
To determine the mechanisms employed by FSH to regulate gene expression
during granulosa cell differentiation, we investigated the functional
promoter regions of the sgk gene at both early and late
stages of granulosa cell differentiation. Deletion and mutation
analyses of the sgk promoter showed that a region between
-63 and -43 bp conferred FSH activation of reporter genes at 6 h
and forskolin mediated activation at 48 h. Based on several
approaches, our results indicate that Sp1 and Sp3 are transcription
factors that contribute to the biphasic regulation of sgk by
the PKA pathway in granulosa cells. First, the G/C-rich box within the
transcriptionally active -63/-43 region contains overlapping
consensus binding sites for Sp1 family members that bind multiple
proteins present in granulosa cell extracts. Second, EMSAs showed that
Sp1 consensus oligonucleotides competed for the binding of granulosa
cell proteins to the -63/-43 oligonucleotide, that recombinant Sp1
bound to this same probe and formed a complex of similar mobility as
complex I, and that an Sp1 antibody supershifted the Sp1/DNA complex.
Complex II, also specifically competed by the Sp1 family consensus
binding sites, was supershifted in the presence of Sp3 antibody.
Furthermore, mutation of the Sp1-binding sites within the G/C box
abolished the formation of both complexes I and II. Transfection
experiments documented that a transgene containing six concatamers of
Sp1-binding sites ligated to a heterologous minimal promoter conferred
high basal and FSH-stimulated activity in granulosa cells. Most
importantly, when the mutant -63 sgk-CAT vector lacking Sp1- and
Sp3-binding activity was transfected into granulosa cells, the basal
and hormone-induced expression observed with the wild type -63 sgk-CAT
transgene was abolished. Although AP-2 sites were present in this
region of the promoter, no evidence of binding or functional activity
was observed. Based on these observations, we conclude that Sp1 and Sp3
bind to the G/C-rich cis-acting DNA element of the
sgk promoter and, independently or coordinately, function as
enhancers to enable FSH/PKA-mediated transcription of the
sgk gene.
Sp1 has been traditionally characterized as a ubiquitous regulator of
basal promoter activity, partly because of its critical role in
transcription from TATA-less promoters (31). Sp3 is an Sp1 family
member previously demonstrated to antagonize Sp1 activity by competing
for Sp1 binding sites (24). Sp3 has also been demonstrated to activate
transcription (32). The results described herein and those of others
(25, 33, 34, 35, 36, 37) indicate that Sp1 and/or Sp3 can also function as
enhancers, enabling hormone-inducible transcription from TATA
box-containing promoters. For example, in other cell systems, putative
functional Sp1-binding sites have been reported in several genes that
exhibit regulated expression similar to the secondary induction of
sgk in differentiated granulosa cells. Bovine cholesterol
side-chain cleavage cytochrome P450 (33, 34, 35), the LH receptor (36), and
the rat progesterone receptor (37) require Sp1 and/or its binding sites
for PKA-mediated induction. CIP1, a cyclin-dependent kinase inhibitor
that is expressed in rat luteal cells (R. L. Robker and J. S.
Richards, unpublished observations) requires Sp1 for a protein kinase
C-mediated induction (25). The results presented herein extend these
observations and provide the first evidence that Sp1 and/or Sp3 binding
to a G/C-rich cis-acting DNA element mediates the biphasic
FSH induction of a specific gene, sgk, in granulosa
cells.
The known mechanisms by which Sp1 family members can mediate
hormone-regulated expression of genes are complex. Regulation of Sp1
binding by phosphorylation (38), by the Sp1-Inhibitor (Sp1-I) (39, 40, 41, 42),
or by competition for binding sites with the repressor, Sp3 (43), can
also control Sp1 activity. Tissue-specific regulation of Sp1 protein
levels may also be critical. For example, the tissues that express the
highest levels of Sp1, ovary, lung, and thymus (Fig. 9C
) (27), also
express the highest levels of sgk (1). However, the lack of
significant detectable changes in Sp1 and Sp3 protein levels or binding
activity during the course of sgk induction suggests that
the functional activation of these factors depends upon a
posttranslational change in Sp1 or Sp3 or a regulated interaction with
other factors (44). Some of the factors with which Sp1 is known to
interact include SF-1, p53, Stat 1, GATA-1, AP-1, NFKB, and estrogen
receptor (35, 45, 46, 47, 48, 49, 50). The sgk promoter does contain a
functional p53 site at -1380/-1345 bp, as well as a glucocorticoid
response element at -1.0 kb, both of which have been shown to be
functional in other cells (1, 51, 52). However, to our knowledge, p53
and Sp1 interactions have thus far been reported only when the binding
sites are in close proximity (45). Furthermore, although the functional
importance of p53 and GR in transactivation has been clearly
demonstrated in other systems, deletion of these upstream regions did
not decrease or modify the expression of sgk transgenes by
FSH in granulosa cells. Although no consensus sequences for factors
known to interact with Sp1 have been identified in the -63/-43
region, the additional factor or cofactor may bind directly to Sp1 or
Sp3 instead of to the DNA. In fact, because both GR and p53 can impact
transcription in the absence of their own consensus sequence binding
sites (53, 52), these factors could potentially interact with Sp1
and/or Sp3 in trans. Based on the biphasic pattern of CREB
phosphorylation, we propose PKA mediates a biphasic change in Sp1/Sp3
activity directly or indirectly, thereby resulting in the biphasic
induction pattern of sgk transcription.
 |
MATERIALS AND METHODS
|
---|
Materials
Ovine FSH was provided by the National Hormone and Pituitary
Program (Baltimore, MD). T was obtained from Steraloids (Keene, NH).
Cell culture reagents were purchased from GIBCO (Grand Island, NY).
Biotrans nylon membrane (0.2 mm) was purchased from ICN Biochemicals
(Cleveland, OH) and [32P]dCTP,
[125I]Protein A, and [125I]cAMP were
obtained from ICN Radiochemical (Costa Mesa, CA). 17ß-Estradiol,
deoxyribonuclease I, soybean trypsin inhibitor, CHX,
-amanitin, and
forskolin were obtained from Sigma (St. Louis, MO). Cell culture dishes
(six-well) were obtained from Corning (Corning, NY). The cAMP antibody
was a gift of Dr. Judith Vaitukaitis (NIH, Bethesda, MD).
[14C]Chloramphenicol was obtained from Amersham
(Arlington Heights, IL), and acetyl coenzyme A, coenzyme A, and
poly(deoxyinosinic-deoxycytidylic)acid [poly(dI-dC)] were purchased
from Pharmacia (Piscataway, NJ). Luciferin was from Boehringer Mannheim
Biochemicals (Indianapolis, IN), recombinant human Sp1 protein was
obtained from Promega (Madison, WI), and the Sp1, Sp3, and AP-2
antibodies and AP-2 competitor DNA were obtained from Santa Cruz (Santa
Cruz, CA). Oligonucleotides were synthesized by Genosys (Woodlands,
TX). The pGAGC6 and pGAM luciferase vectors were gifts of Dr. Jeffrey
Kudlow (University of Alabama at Birmingham, Birmingham, AL).
Methods
Primary Granulosa Cell Culture
Holtzman Sprague Dawley immature female rats (Harlan, Indianapolis, IN)
delivered on day 23 of age were injected subcutaneously with 1.5 mg
17ß-estradiol once daily on days 24, 25, and 26 of age. Animals were
treated in accordance with the principles and procedures outlined in
the "Guidelines for Care and Use of Experimental Animals." Ovaries
were isolated from rats on day 27 for the harvest of granulosa cells
exhibiting a small antral phenotype as previously described (54).
Briefly, cells were isolated from the ovaries by needle puncture (22
gauge) into media containing DMEM, F12, 30 mM
NaHCO3, 20 mM HEPES, and 100 IU/ml
penicillin-streptomycin. Granulosa cells were treated with 20 µg/ml
trypsin, 300 µg/ml soybean trypsin inhibitor, and 160 µg/ml
deoxyribonuclease I to remove dead cells. After the cells were washed
twice in DMEM-F12, they were plated on serum-coated, six-well culture
dishes in 3 ml of media. Cells were incubated in 95% air, 5%
CO2 at 37 C. To allow efficient attachment of cells before
initiation of treatments, cells were incubated overnight in hormone and
serum-free medium unless indicated otherwise. The following morning (16
h later), FSH (50 ng/ml), T (10 ng/ml), or forskolin (10
µM) were added for the preparation of RNA, protein, or
cell extracts for EMSAs. Where indicated, CHX (10 µg/ml) or
-amanitin (30 µg/ml) were added either 30 min before hormone
addition or after 41 h of culture with FSH/T to inhibit protein
and RNA synthesis, respectively. Similar granulosa cell cultures were
processed for transient transfections.
In Situ Hybridization
Ovaries isolated from adult cycling rats were fixed in 4%
paraformaldehyde in PBS (80 mM
Na2HPO4, 20 mM
NaH2PO4, 100 mM NaCl) overnight at
4 C before dehydration and paraffin embedding. Sections (6 µm) were
baked at 42 C overnight onto 3-amino propyltriethoxysilane-coated
slides. Slides were prehybridized, hybridized, washed, exposed, and
developed as previously described (55). The 35S-labeled
sense and antisense riboprobes were produced by transcription from the
T3 and T7 promoters, respectively, on the NheI-digested
pBS-sgk vector as previously described (55).
RNA Isolation and Northern Analysis
RNA was isolated as previously described (56) from granulosa cell
cultures using buffer containing 1% Nonidet P-40, followed by
phenol/chloroform extraction, ethanol precipitation, resuspension in
water previously treated with diethyl pyrocarbonate, and quantification
by absorbance at 260 nm. For Northern analysis, RNA samples (20 µg)
were denatured at 55 C for 15 min in 45% formamide-5.4% formaldehyde
and resolved by electrophoresis on formaldehyde-agarose gels at room
temperature. Acridine orange staining allowed assessment of RNA ladder
migration and confirmation of equal sample loading by the UV intensity
of 28 S and 18 S ribosomal RNA bands. After the RNA was transferred to
a nylon membrane, the blot was baked for 1 h at 80 C,
prehybridized, and hybridized with 1 x 106 cpm/ml
sgk cDNA probe (1). Blots were washed according to ICN
specifications and exposed to x-ray film at -70 C. All results were
quantified using a Betascope analyzer. The sgk cDNA probe
was labeled as previously described using a random primers and
[
-32P]dCTP (57).
Protein Preparation and Western Analysis
Granulosa cells cultured in FSH/T or forskolin were harvested at
selected times and homogenized to prepare soluble cell extracts as
previously described (58). Extracts of lung, muscle, thymus, and kidney
tissues were prepared similarly. Protein was measured using a 1:5
dilution of Bradford reagent in microtiter plates for colorimetric
detection at 590 nm (59). Cell extracts were stored at -70 C until
Western analyses were performed. Protein samples (100 µg) were
denatured for 10 min at 100 C in 5x SDS loading dye (60).
One-dimensional SDS-PAGE with 4.5% stacking and 10% separating
acrylamide gels was used to resolve proteins. Proteins were transferred
to 0.45-µm nitrocellulose membranes at 50 V for 4 h in 125
mM Tris-Base, 100 mM glycine, and then blocked
for 1 h in PBS (80 mM Na2HPO4,
20 mM NaH2PO4, 100 mM
NaCl, pH 7.5), containing 5% milk, 0.1% Tween-20. After one 20-min
incubation in wash solution (1% milk in PBS and 0.1% Tween-20),
filters were incubated 1 h with appropriate dilutions of Sgk
antibody (1:10,000), Sp1 antibody (1:1000), or Sp3 antibody (1:1000).
After three washes (10 min each), blots probed for Sgk or Sp1 proteins
were incubated with 1:10,000 anti-rabbit-horseradish peroxidase, washed
as before, and detected using the enhanced chemiluminesence assay
system. Other blots probed for Sp1 and Sp3 protein were incubated with
125I-labeled protein A (1:1000) for 3 h at room
temperature, washed, and exposed to film. Recombinant Sgk or Sp1
proteins were run as positive controls.
Production of Polyclonal anti-Sgk Antibodies
Sgk cDNA with an in-frame hemagglutinin epitope tag sequence
on the 5'-end of the gene was inserted into a T7 promoter-driven pET
vector and expressed in HMS174 Escherichia coli. Isopropyl
ß-D thiogalactopyranoside induction and activation of the
T7 promoter in a 2-liter bacterial culture produced a major protein at
55 kDa protein that was absent in a nontransformed culture. The
bacterial extract was fractionated by preparative SDS-PAGE from which
Sgk protein was excised by solidifying the Sgk-polyacrylamide slice at
200 C and grinding it into a powder. The rabbit Sgk polyclonal
antibodies were produced by Babco Berkeley Antibody Company (Richmond,
CA). Briefly, preimmune serum samples were drawn before antigen
injection. Rabbits were initially immunized with 500 µg of E.
coli-produced Sgk antigen in complete Freunds adjuvant.
Twenty-one days later, the animals were reinjected with 250 µg Sgk in
incomplete Freunds adjuvant, and booster shots of 250 µg Sgk were
given on days 42, 63, and 84. On day 94, final serum was collected and
tested by Western blots of fractionated Con8 rat mammary tumor cell
extracts, which is the cell line from which sgk was
originally cloned. A 1:10,000 dilution of the polyclonal anti-Sgk
antibody specifically recognized the 55-kDa Sgk protein.
cAMP RIA
cAMP was measured in media from granulosa cell cultures by RIA as
previously described (61). Data were analyzed using the Assay Zap
computer program (Biosoft, Cambridge, U.K.) and expressed as mean
± SEM.
Transient Transfections and CAT Assays
Plasmid DNA was purified by alkaline lysis and centrifugation on two
cesium chloride gradients as described (62). Using calcium
phosphate precipitation, a total of 20 µg of plasmid DNA were
transfected, as previously described (63), into primary granulosa cell
cultures at two distinct culture periods. To assay regulatory elements
involved in the immediate-early induction of sgk, granulosa
cells were cultured overnight (16 h) in serum and hormone-free
conditions before transfection. To assay the elements involved in
sgk induction in differentiated granulosa cells, cells were
immediately cultured in the presence of FSH/T for 37 h before the
4-h transfection. Cells were then washed and treated with forskolin for
6 h, resulting in a cumulative culture period of 48 h, at
which time granulosa cells express maximal levels of sgk.
Briefly, to make precipitates, a mixture of plasmid DNAs,
CaCl2, and water was added dropwise in 150-µl aliquots to
an equal volume of HEPES-buffered saline (283 mM NaCl, 50
mM HEPES, 1.5 mM
NaH2PO4, pH 7.05). After a 30-min incubation,
300 µl of the resulting precipitate were added to each well of cells.
Four hours later, cells were gently washed (2x) with HBSS without
calcium or magnesium before addition of fresh DMEM-F12. At this time,
FSH/T or forskolin was added to the medium for 6-h incubations. After
the incubation, cells were harvested. For CAT assays (64), cells were
lysed by repeated freeze/thaw cycles. CAT activity was measured using
15 µg of the resulting total protein, 0.05 µCi of
[14C]chloramphenicol, and 10 mM acetyl
coenzyme A and incubated for 2 h (Fig. 4
) or 7 h (Fig. 8
) at
37 C. Extracted chloramphenicol was analyzed by TLC. Data were
quantified with a Betascope analyzer. Luciferase activity was assayed
as previously described (65).
Construct Generation
Sgk-CAT reporter plasmids (-4000 sgk-CAT, -1500 sgk-CAT, and -360
sgk-CAT) contained -4 to +0.051 kb (and deletions thereof) of the rat
sgk promoter sequence linked to the coding region of
bacterial CAT gene in the vector pBLCAT3 as previously described (2, 51). The -78 sgk-CAT construct was generated from -360 sgk-CAT by
digestion with ApaI at -0.078 kb of the promoter and with
PstI in the vector multiple-cloning cassette. The
incompatible ends were filled in and then blunt-end ligated. The -35
sgk-CAT construct was created by ligating an oligonucleotide
corresponding to -35 to +40 bp of the sgk promoter into
XbaI and SalI sites of the pCAT-Basic
multiple-cloning cassette. Oligonucleotides corresponding to -63 to
-43 bp of the sgk promoter with SalI and
HindIII restriction sites (sequence detailed below) were
cloned into the -35 sgk-CAT construct to create the -63 wild type and
mutant sgk-CAT constructs. Positive clones were confirmed by
restriction mapping and DNA sequencing.
Whole Cell Extracts
Granulosa cells cultured overnight in serum-free medium were stimulated
with FSH/T for 0, 2, 12, 24, or 48 h as indicated. At each timed
endpoint, cells were washed, scraped in PBS, and collected by
centrifugation at 4 C for 5 min at 1000 x g. Cells
were resuspended in whole cell extract buffer [10 mM Tris,
1 mM EDTA, 1 mM dithiothreitol (DTT), 400
mM KCl, 10% glycerol, 1 mM
phenylmethylsulfonyl fluoride, 1 mM vanadate, 1
mM diethyldithiocarbamic acid, 0.1 mg/ml aprotinin, PIC I,
and PIC II] and then lysed by repeated freeze/thaw cycles before
centrifugation to isolate soluble protein (66). Concentrations of
soluble protein in each sample were determined by Bradford assay.
EMSAs
Whole cell extracts (1.5 µg) were incubated for 30 min with 400 pg of
probe (labeled with DNA polymerase (Klenow) and
[
-32P]dCTP) in the presence of 100 mM KCl,
5 µg poly(dI-dC), 15 mM Tris-HCl (pH 7.5), 5
mM DTT, 1 mM EDTA, 5 mM
MgCl2, and 12% glycerol in a 20 µl volume.
Sgk competitors and probes were prepared by annealing
complimentary oligonucleotides spanning -78/-35
5'AGGCCG-AGTGGCTTCCTGGTCCCGCCTGCCCCGCCCCCTGGAG-GCTC 3',
-78/-50 5'AGGCCGAGTGGCTTCCTGGTCCCGCCTGCCCC 3', -55/-35
5'AGGTGCCCCGCCCCCTGGAGGCTC 3', or -63/-43 wild type
5'TGTCCCGCCTGCCCCGCCCCCTG 3' of the sgk promoter. The
-63/43 mutant oligonucleotide contains a mutated G/C box
5'-TGTCCCGCCTGCCCCGAACCCTG-3'. Sp1 competitor DNA was
prepared by digestion of the pGAGC6 plasmid with XhoI and
XbaI to isolate a 60-bp fragment containing six Sp1 sites.
Unlabeled competitor DNA or oligonucleotides (100-fold molar excess)
were added where indicated. Sp1 and Sp3 antibodies (1 µg) were
preincubated with or without whole cell extract for 30 min at room
temperature before addition of probe. In these experiments, the amount
of poly(dI-dC) per reaction was reduced to 3.75 µg. Recombinant human
Sp1 protein was diluted 1:10 in 5 µM ZnSO4,
50 mM KCl, 1 mM DTT, 12 mM HEPES
(pH 7.0), 6 mM MgCl2, 0.05% NP-40, and 50%
glycerol. Where indicated, diluted Sp1 (1 µl) was incubated in the
presence of other reaction components with 1 µg BSA. Reactions were
resolved by electrophoresis on 5% acrylamide, 0.5x TBE, 2.5%
glycerol gels before drying and autoradiography.
Data Presentation
Representative experiments for Northern, Western, in situ
hybridization, and EMSAs are included as figures. Data from cAMP, CAT,
and luciferase assays were normalized and shown as the mean ±
SEM. Each experiment was repeated at least three times.
 |
FOOTNOTES
|
---|
Address requests for reprints to: JoAnne S. Richards, Department of Cell Biology, Baylor College of Medicine, Houston, Texas 77030.
This study was supported by NIH Grants CA-71514 (to G.L.F.) and
HD-16272 (to J.S.R.).
Received for publication May 16, 1997.
Revision received September 2, 1997.
Accepted for publication September 18, 1997.
 |
REFERENCES
|
---|
-
Webster MK, Goya L, Ge Y, Maiyar AC, Firestone GL 1993 Characterization of sgk, a novel member of the
serine/threonine protein kinase gene family which is transcriptionally
induced by glucocorticoids and serum. Mol Cell Biol 13:20312040[Abstract]
-
Webster MK, Goya L, Firestone GL 1993 Immediate-early
transcriptional regulation and rapid mRNA turnover of a putative
serine/threonine kinase. J Biol Chem 268:1148211485[Abstract/Free Full Text]
-
Imaizumi K, Tsuda M, Wanaka A, Tohyama M, Takagi T 1994 Differential expression of sgk mRNA, a member of the ser/thr
protein kinase gene family, in rat brain after CNS injury. Mol Brain
Res 26:189196[Medline]
-
Simmons DL, Neel BG, Stevens R, Evett G, Erikson RL 1992 Identification of an early-growth-response gene encoding a novel
putative protein kinase. Mol Cell Biol 12:41634169
-
Donahue PJ, Alberts GF, Guo Y, Winkles JA 1995 Identification
by targeted differential display of an immediate-early gene encoding a
putative serine/threonine kinase. J Biol Chem 270:1035110357[Abstract/Free Full Text]
-
Li B, Ouyang B, Pan H, Reissmann PT, Slamon DJ, Arceci R, Lu
L, Dai W 1996 prk, a cytokine-inducible human protein
serine/threonine kinase whose expression appears to be down-regulated
in lung carcinomas. J Biol Chem 271:1940219408[Abstract/Free Full Text]
-
Alliston TN, Richards JS Hormonal regulation of serum,
glucocorticoid regulated kinase, sgk, in rat granulosa
cells. Program of the 29th meeting of The Society for the Study of
Reproduction, London, Ontario, Canada, 1996, p 98 (Abstract 166)
-
Rao MC, Midgley Jr AR, Richards JS 1978 Hormonal regulation
of ovarian cellular proliferation. Cell 14:7178[Medline]
-
Richards JS 1994 Hormonal control of gene expression in the
ovary. Endocr Rev 15:725751[Medline]
-
Hirshfield AN 1985 Comparison of granulosa cell proliferation
in small follicles of hypophysectomized, prepubertal and immature rats.
Biol Reprod 32:979987[Abstract]
-
Sicinski P, Donaher JL, Geng Y, Parker SB, Gardner H, Park MY,
Robker RL, Richards JS, McGinnis LK, Biggers JD, Eppig JJ, Bronson RT,
Elledge SJ, Weinberg RA 1996 Cyclin D2 is an FSH-responsive gene
involved in gonadal cell proliferation and oncogenesis. Nature 384:470474[CrossRef][Medline]
-
Hickey GJ, Chen S, Besman MJ, Shively JE, Hall PF,
Gaddy-Kurten D, Richards JS 1988 Hormonal regulation, tissue
distribution, and content of aromatase cytochrome P450 messenger
ribonucleic acid and enzyme in rat ovarian follicles and corpora lutea.
Endocrinology 122:14261436[Abstract]
-
Goldring NB, Durica JM, Lifka J, Hedin L, Ratoosh SL, Miller
WL, Orly J 1987 Cholesterol side-chain cleavage P450 messenger
ribonucleic acid: evidence for hormonal regulation in rat ovarian
follicles and constitutive expression in corpora lutea. Endocrinology 120:19421950[Abstract]
-
Segaloff DL, Wang H, Richards JS 1990 Hormonal regulation of
luteinizing hormone/chorionic gonadotropin receptor mRNA in rat ovarian
cells during follicular development and luteinization. Mol Endocrinol 4:18561865[Abstract]
-
Leung PCK, Steele GL 1992 Intracellular signaling in the
gonads. Endocr Rev 13:476498[Abstract]
-
Habener JF, Miller CP, Vallejo M 1995 cAMP-dependent
regulation of gene transcription by cAMP response element-binding
protein and cAMP response element modulator. Vitam Horm 51:157[Medline]
-
Hunter T, Karin M 1992 The regulation of transcription by
phosphorylation. Cell 70:375387[Medline]
-
Gonzalez GA, Montminy MR 1989 Cyclic AMP stimulates
somatostatin gene transcription by phosphorylation of CREB at serine
133. Cell 59:675680[Medline]
-
Carlone DL, Richards JS 1996 Functional interaction,
phosphorylation and levels of 3',5'-cyclic adenosine
monophosphate-regulatory element binding protein and steroidogenic
factor-1 mediate hormone-regulated and constitutive expression of
aromatase in gonadal cells. Mol Endocrinol 11:292304[Abstract/Free Full Text]
-
Richards JS 1981 Maturation of ovarian follicles: actions and
interactions of pituitary and ovarian hormones on follicular cell
differentiation. Physiol Rev 90:5189
-
Fitzpatrick SL, Richards JS 1991 Regulation of cytochrome P450
aromatase messenger ribonucleic acid and activity by steroids and
gonadotropins in rat granulosa cells. Endocrinology 129:14521462[Abstract]
-
Beelman CA, Parker R 1994 Differential effects of
translational inhibition in cis and in trans
on the decay of the unstable yeast MFA2 mRNA. J Biol Chem 269:96879692[Abstract/Free Full Text]
-
Neish AS, Khachigian LM, Park A, Baichwal VR, Collins T 1995 Sp1 is a component of the cytokine-inducible enhancer in the promoter
of vascular cell adhesion molecule-1. J Biol Chem 270:2890328909[Abstract/Free Full Text]
-
Kingsley C, Winoto A 1992 Cloning of GT box-binding proteins:
a novel Sp1 multigene family regulating T-cell receptor gene
expression. Mol Cell Biol 12:42514261[Abstract]
-
Biggs JR, Kudlow JE, Kraft AS 1996 The role of the
transcription factor Sp1 in regulating the expression of the
WAF1/CIP1 gene in U937 leukemic cells. J Biol Chem 271:901906[Abstract/Free Full Text]
-
Briggs MR, Kadonaga JT, Bell SP, Tjian R 1986 Purification and
biochemical characterization of the promoter-specific transcription
factor, Sp1. Science 234:4752[Medline]
-
Saffer JD, Jackson SP, Annarella MB 1991 Developmental
expression of Sp1 in the mouse. Mol Cell Biol 11:21892199[Medline]
-
Gaytan F, Morales C, Bellido C, Aguilar E, Sanchez-Criado JE 1996 Proliferative activity in the different compartments in cycling
rats estimated by the 5-bromodeoxyuridine technique. Biol Reprod 54:13561365[Abstract]
-
Hirshfield AN 1986 Patterns of (3H) thymidine
incorporation differ in immature rats and mature, cycling rats. Biol
Reprod 34:229235[Abstract]
-
Bortolussi M, Marini G, Reolon ML 1979 A histochem-ical
study of the binding of 125I-labeled hCG to the rat ovary
throughout the estrus cycle. Cell Tissue Res 197:213226[Medline]
-
Jones NC, Rigby PWJ, Ziff EB 1988 Trans-acting protein factors
and the regulation of eukaryotic transcription: lessons from studies on
DNA tumor viruses. Genes Dev 2:267281[CrossRef][Medline]
-
Prowse DM, Bolgan L, Molnar A, Dotto GP 1997 Involvement of
the Sp3 transcription factor in induction of p21Cip1/WAF1
in keratinocyte differentiation. J Biol Chem 272:13081314[Abstract/Free Full Text]
-
Venepally P, Waterman MR 1995 Two Sp1-binding sites mediate
cAMP-induced transcription of the bovine CYP11A gene through the
protein kinase A signaling pathway. J Biol Chem 270:2540225410[Abstract/Free Full Text]
-
Chou S-J, Lai K-N, Chung B-C 1996 Characteri-zation of the
upstream sequence of the human CYP11A1 gene for cell type-specific
expression. J Biol Chem 271:2212522129[Abstract/Free Full Text]
-
Liu Z, Simpson ER 1997 Steroidogenic factor-1 and Sp1 are
required for regulation of bovine CYP11A gene expression in bovine
luteal cells and adrenal Y1 cells. Mol Endocrinol 11:127137[Abstract/Free Full Text]
-
Hu YL, Lei ZM, Rao ChV 1996 cis-acting elements and
trans-acting proteins in the transcription of chorionic
gonadotropin/luteinizing hormone receptor gene in human choriocarcinoma
cells and placenta. Endocrinology 137:38973905[Abstract]
-
Park-Sarge O-K, Sarge KD 1995 Cis-regulatory
elements conferring cyclic 3', 5'-adenosine monophosphate
responsiveness of the progesterone receptor gene in
transfected rat granulosa cells. Endocrinology 136:54305437[Abstract]
-
Leggett RW, Armstrong SA, Barry D, Mueller CR 1995 Sp1 is
phosphorylated and its DNA binding activity down-regulated upon
terminal differentiation of the liver. J Biol Chem 270:2587925884[Abstract/Free Full Text]
-
Chen LI, Nishinaka T, Kwan K, Kitabayashi I, Yokoyama K,
Florence FY-H, Grünwald S, Chiu R 1994 The retinoblastoma gene
product RB stimulates Sp1-mediated transcription by liberating Sp1 from
a negative regulator. Mol Cell Biol 14:43804389[Abstract]
-
Shen WK, Kim HS, Tsai SY 1995 Stimulation of human insulin
receptor gene expression by retinoblastoma gene product. J Biol
Chem 270:2052520529[Abstract/Free Full Text]
-
Inagaki Y, Truter S, Tanaka S, Di Liberto M, Ramirez F 1995 Overlapping pathways mediate the opposing actions of tumor necrosis
factor-
and transforming growth factor-ß on
2(I) collagen gene
transcription. J Biol Chem 270:33533358[Abstract/Free Full Text]
-
Sancéau J, Kaisho T, Hirano T, Weitzerbin J 1995 Triggering of the human interleukin-6 gene by interferon-
and tumor
necrosis factor-
in monocytic cells involves cooperation between
interferon regulatory factor-1, NFKB, and Sp1 transcription factors.
J Biol Chem 270:2792027931[Abstract/Free Full Text]
-
Hagen G, Dennig J, Preib A, Beato M, Suske G 1995 Functional
analyses of the transcription factor Sp4 reveal properties distinct
from Sp1 and Sp3. J Biol Chem 270:2498924994[Abstract/Free Full Text]
-
Blau J, Xiao H, McCracken S, OHare P, Greenblatt J, Bentley
D 1996 Three functional classes of transcriptional activation domain.
Mol Cell Biol 16:20442055[Abstract]
-
Gualberto A, Baldwin Jr AS 1995 p53 and Sp1 interact and
cooperate in the tumor necrosis factor-induced transcriptional
activation of the HIV-1 long terminal repeat. J Biol Chem 270:1968019683[Abstract/Free Full Text]
-
Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ 1995 Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270:3026430267[Abstract/Free Full Text]
-
Merika M, Orkin SH 1995 Functional synergy and physical
interactions of the erythroid transcription factor GATA-1 with the
Krüppel family proteins Sp1 and EKLF. Mol Cell Biol 15:24372447[Abstract]
-
Noti JD, Reinemann BC, Petrus MN 1996 Sp1 binds two sites in
the CD11c promoter in vivo specifically in myeloid cells and
cooperates with AP1 to activate transcription. Mol Cell Biol 16:29402950[Abstract]
-
Perkins ND, Agranoff AB, Pascal E, Nabel GJ 1994 An
interaction between the DNA-binding domains of RelA (p65) and Sp1
mediates human immunodeficiency virus gene activation. Mol Cell Biol 14:65706583[Abstract]
-
Porter W, Wang F, Wang W, Duan R, Safe S 1996 Role of estrogen
receptor/Sp1 complexes in estrogen-induced heat shock protein 27 gene
expression. Mol Endocrinol 10:13711378[Abstract]
-
Maiyar AC, Huang AJ, Phu PT, Cha HH, Firestone GL 1996 p53
stimulates promoter activity of the sgk serum/glucocorticoid
inducible serine/threonine protein kinase gene in rodent mammary
epithelial cells. J Biol Chem 271:1241412422[Abstract/Free Full Text]
-
Maiyar AC, Phu PT, Huang AJ, Firestone GL 1997 Repression of
glucocorticoid receptor transactivation and DNA binding of a
glucocorticoid response element within the
serum/glucocorticoid-inducible protein kinase gene promoter by the p53
tumor suppressor protein. Mol Endocrinol 11:312329[Abstract/Free Full Text]
-
Stocklin E, Wissler M, Gouilleux F, Groner B 1996 Functional
interactions between Stat5 and the glucocorticoid receptor. Nature 383:726728[CrossRef][Medline]
-
Ratoosh SL, Richards JS 1985 Regulation of the content and
phosphorylation of RII by adenosine 3', 5'-monophosphate, follicle
stimulating hormone, and estradiol in cultured granulosa cells.
Endocrinology 117:917927[Abstract]
-
Wilkensen DG 1993 In Situ Hybridization. In: Stern
CD, Holland PWH (eds) Essential Developmental Biology, A Practical
Approach. Oxford University Press, New York, pp 258263
-
Pelham HRB 1982 A regulatory upstream promoter element in the
Drosophila Hsp70 heat shock gene. Cell 30:517528[Medline]
-
Feinberg A, Vogelstein B 1984 Technique for radiolabeling DNA
restriction nuclease fragments to high specific activity. Anal Biochem 137:266267[Medline]
-
Sirois J, Richards JS 1992 Purification and characterization
of a novel, distinct isoform of prostaglandin endoperoxide synthase
induced by human chorionic gonadotropin in granulosa cells of rat
preovulatory follicles. J Biol Chem 267:63826388[Abstract/Free Full Text]
-
Bradford MM 1976 A rapid and sensitive method for the
quantitation of microgram quantities of protein utilizing the principle
of protein-dye binding. Anal Biochem 72:248254[CrossRef][Medline]
-
Laemmli UK 1970 Cleavage of structural proteins during the
assembly of the head of bacteriophage T4. Nature 227:680685[Medline]
-
Richards JS, Bogovich K 1987 Effects of human chorionic
gonadotropin and progesterone on follicular development in the immature
rat. Endocrinology 111:14291438[Medline]
-
Sambrook J, Fritsch EF, Maniatis T 1989 Molecular Cloning: A
Laboratory Manual, ed. 2. Cold Spring Harbor Laboratory, Cold Spring,
NY, pp 1.341.48
-
Sirois J, Richards JS 1993 Transcriptional regulation of the
rat prostaglandin endoperoxide synthase-2 gene in granulosa cells.
J Biol Chem 268:2193121938[Abstract/Free Full Text]
-
Gorman CM, Moffat LF, Howard BH 1982 Recombinant genomes which
express chloramphenicol acetyltransferase in mammalian cells. Mol Cell
Biol 2:10441051[Medline]
-
Dajee M, Kazansky AV, Raught B, Hocke GM, Fey GH, Richards JS 1996 Prolactin induction of the
2-macroglobulin gene in rat ovarian
granulosa cells: Stat 5 activation and binding to the interleukin-6
response element. Mol Endocrinol 10:171184[Abstract]
-
Welte T, Garimorth K, Philipp S, Doppler W 1994 Prolactin-dependent activation of a tyrosine phosphorylated DNA binding
factor in mouse mammary epithelial cells. Mol Endocrinol 8:10911102[Abstract]